Adolfo Ramirez-Zamora
Overview
Explore the profile of Adolfo Ramirez-Zamora including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
139
Citations
1082
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Martinez-Nunez A, Rozell C, Little S, Tan H, Schmidt S, Grill W, et al.
Front Hum Neurosci
. 2025 Mar;
19:1544994.
PMID: 40070487
The Deep Brain Stimulation (DBS) Think Tank XII was held on August 21st to 23rd. This year we showcased groundbreaking advancements in neuromodulation technology, focusing heavily on the novel uses...
2.
Acevedo T G, Pappas M, Wolfe J, Wong J, Ramirez-Zamora A, Zeilman P, et al.
Annu Int Conf IEEE Eng Med Biol Soc
. 2025 Mar;
2024:1-4.
PMID: 40040167
Dysarthria is a common speech disorder in Parkinson's Disease (PD). The Dysarthria Analyzer software has emerged as a viable tool for automatic speech analysis in PD and quantification of dysarthria...
3.
Stanslaski S, Summers R, Tonder L, Tan Y, Case M, Raike R, et al.
NPJ Parkinsons Dis
. 2024 Sep;
10(1):174.
PMID: 39289373
Adaptive deep brain stimulation (aDBS) is an emerging advancement in DBS technology; however, local field potential (LFP) signal rate detection sufficient for aDBS algorithms and the methods to set-up aDBS...
4.
Rusch C, Beke M, Nieves Jr C, Mai V, Stiep T, Tholanikunnel T, et al.
Nutrients
. 2024 Sep;
16(17).
PMID: 39275262
Parkinson's disease is associated with gastrointestinal (GI) dysfunction, including constipation symptoms and abnormal intestinal permeability and inflammation. A Mediterranean diet (MediDiet) may aid in disease management This parallel, randomized, controlled...
5.
A Randomized Controlled Trial on Automated Vehicle Technologies for Drivers With Parkinson's Disease
Classen S, Giang W, Rajkhan A, Zheng H, Gibson B, Patel B, et al.
OTJR (Thorofare N J)
. 2024 Sep;
45(2):219-231.
PMID: 39263869
Parkinson's disease (PD) negatively affects driver fitness. Few studies document the benefits of in-vehicle information systems (IVIS) and advanced-driver assistance systems (ADAS), the focus of this study, for drivers with...
6.
Tang H, Lu Y, Okun M, Donahoo W, Ramirez-Zamora A, Wang F, et al.
Mov Disord
. 2024 Aug;
39(11):1960-1970.
PMID: 39189078
Background: Previous studies have suggested that glucagon-like peptide-1 receptor agonists (GLP-1RAs) may have a disease-modifying effect in the development of Parkinson's disease (PD), but population studies yielded inconsistent results. Objective:...
7.
Guarin D, Wong J, McFarland N, Ramirez-Zamora A, Vaillancourt D
Parkinsonism Relat Disord
. 2024 Aug;
127:107104.
PMID: 39153421
Background: Evaluation of disease severity in Parkinson's disease (PD) relies on motor symptoms quantification. However, during early-stage PD, these symptoms are subtle and difficult to quantify by experts, which might...
8.
Johnson K, Giordano J, Ramirez-Zamora A, San Luciano M, Miocinovic S, Okun M, et al.
Front Hum Neurosci
. 2024 Jul;
18:1441212.
PMID: 38993328
No abstract available.
9.
Guarin D, Wong J, McFarland N, Ramirez-Zamora A
IEEE Trans Neural Syst Rehabil Eng
. 2024 Jun;
32:2293-2301.
PMID: 38905096
Introduction: Parkinson's disease (PD) is characterized by motor symptoms whose progression is typically assessed using clinical scales, namely the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS). Despite its reliability,...
10.
Gopinath A, Ramirez-Zamora A, Franks S, Riaz T, Smith A, Dizon G, et al.
J Parkinsons Dis
. 2024 May;
14(4):883-888.
PMID: 38788089
Background: Parkinson's disease (PD) is the second most common neurodegenerative disorder, with genetic factors accounting for about 15% of cases. There is a significant challenge in tracking disease progression and...